Cellebrite DI Ltd.
CLBT
$15.68
-$0.32-2.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | 19.27M | -23.81M | -71.37M | -14.65M | |
| Total Depreciation and Amortization | 2.73M | 2.58M | 2.68M | 2.62M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3.75M | 40.80M | 83.53M | 34.46M | |
| Change in Net Operating Assets | 40.22M | -5.05M | -4.80M | 21.40M | |
| Cash from Operations | 65.97M | 14.51M | 10.04M | 43.83M | |
| Capital Expenditure | -3.18M | -2.07M | -1.50M | -2.26M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -12.77M | -31.19M | -80.10M | 5.42M | |
| Cash from Investing | -15.95M | -33.26M | -81.60M | 3.16M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 6.73M | 3.32M | 5.07M | 4.53M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 0.00 | -- | -- | -- | |
| Cash from Financing | 6.73M | 3.32M | 5.07M | 4.53M | |
| Foreign Exchange rate Adjustments | -1.44M | -49.00K | -600.00K | 932.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 55.31M | -15.48M | -67.09M | 52.45M | |